We are live on
!
Find out more
BLAM
Bourne Lent Asset Management Portfolio holdings
AUM
$272M
1-Year Est. Return
30.95%
This Fund
S&P 500
This Quarter
Est. Return
+9.89%
1 Year Est. Return
+30.95%
3 Year Est. Return
+75.66%
5 Year Est. Return
+99.24%
10 Year Est. Return
+591.34%
AUM
$233M
AUM Growth
+$3.34M
(+1.5%)
Cap. Flow
-$13.5M
Cap. Flow
% of AUM
-5.81%
Top 10 Holdings %
Top 10 Hldgs %
71.03%
Holding
65
New
7
Increased
7
Reduced
23
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$383K |
| 2 |
NVIDIA
NVDA
|
+$226K |
| 3 |
Symbotic
SYM
|
+$224K |
| 4 |
Boeing
BA
|
+$221K |
| 5 |
Rio Tinto
RIO
|
+$214K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$6.17M |
| 2 |
Intuitive Surgical
ISRG
|
+$1.46M |
| 3 |
Idexx Laboratories
IDXX
|
+$1.18M |
| 4 |
Tompkins Financial
TMP
|
+$1.04M |
| 5 |
AT&T
T
|
+$924K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.38% |
| 2 | Healthcare | 30.59% |
| 3 | Communication Services | 10.26% |
| 4 | Industrials | 5.75% |
| 5 | Consumer Discretionary | 4.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Idexx Laboratories
IDXX
$42.9B
| $28.7M | 12.3% |
70,336
-3,050
| -4% | -$1.18M |
|
2
Microsoft
MSFT
$2.84T
| $24.5M | 10.5% |
102,120
-37
| -0% | -$8.88K |
|
3
Adobe
ADBE
$89.5B
| $24.3M | 10.42% |
72,239
-2,385
| -3% | -$763K |
|
4
Apple
AAPL
$4.89T
| $22.3M | 9.56% |
171,627
-4,279
| -2% | -$612K |
|
|
5
Bristol-Myers Squibb
BMY
$127B
| $15.2M | 6.53% |
211,653
-81,875
| -28% | -$6.17M |
|
6
Alphabet (Google) Class C
GOOG
$3.9T
| $11.9M | 5.12% |
134,650
-3,550
| -3% | -$339K |
|
|
7
Intuitive Surgical
ISRG
$121B
| $11M | 4.72% |
41,479
-5,991
| -13% | -$1.46M |
|
|
8
Alphabet (Google) Class A
GOOGL
$3.91T
| $10.8M | 4.62% |
122,050
-2,890
| -2% | -$275K |
|
9
Paychex
PAYX
$40.4B
| $9.7M | 4.16% |
83,957
-1,300
| -2% | -$152K |
|
10
Cisco
CSCO
$450B
| $7.27M | 3.11% |
152,549
-3,691
| -2% | -$168K |
|
11
Quanta Services
PWR
$93.9B
| $5.83M | 2.5% |
40,920
-2,480
| -6% | -$352K |
|
12
United Parcel Service
UPS
$97.6B
| $5M | 2.14% |
28,748
| – | – |
|
13
Pacific Biosciences
PACB
$422M
| $4.84M | 2.07% |
591,450
+7,300
| +1% | +$62.9K |
|
14
Amazon
AMZN
$2.5T
| $4.47M | 1.92% |
53,190
-310
| -0.6% | -$30.6K |
|
15
Qualcomm
QCOM
$176B
| $4.04M | 1.73% |
36,710
+50
| +0.1% | +$5.85K |
|
16
Booking.com
BKNG
$138B
| $4M | 1.71% |
49,625
| – | – |
|
17
Nutrien
NTR
$32.7B
| $3.13M | 1.34% |
42,792
-700
| -2% | -$55.3K |
|
18
Enbridge
ENB
$124B
| $2.75M | 1.18% |
70,397
+500
| +0.7% | +$19.6K |
|
19
Amgen
AMGN
$203B
| $2.56M | 1.1% |
9,730
-272
| -3% | -$72.9K |
|
20
Johnson & Johnson
JNJ
$635B
| $2.56M | 1.1% |
14,466
-1,040
| -7% | -$180K |
|
21
L3Harris
LHX
$55.9B
| $2.1M | 0.9% |
10,090
| – | – |
|
22
Pfizer
PFE
$140B
| $1.89M | 0.81% |
36,805
-1,174
| -3% | -$56.3K |
|
23
Berkshire Hathaway Class A
BRK.A
$1.07T
| $1.87M | 0.8% |
4
| – | – |
|
24
Mastercard
MA
$477B
| $1.74M | 0.74% |
4,998
| – | – |
|
25
Visa
V
$677B
| $1.7M | 0.73% |
8,200
-500
| -6% | -$101K |
|
Similar funds
SC
SC
AGP
SFPG
TP
S
SS
LAM
Bourne Lent Asset Management's Q4 2022 Portfolio in Review
As of Q4 2022, Bourne Lent Asset Management held 65 positions worth $233M, up 1.5% from $230M the previous quarter. Its ten largest holdings account for 71% of the portfolio.
Bourne Lent Asset Management withdrew a net $13.5M in Q4 2022, closing 2 positions and reducing 23 holdings. Its most notable exit was Warner Bros, an estimated $261K position sold in full.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Healthcare and Communication Services.
Against the trend, Bourne Lent Asset Management opened a new position in SPDR Gold Trust worth $403K.
- Bourne Lent Asset Management's largest Q4 2022 buy was SPDR Gold Trust: 2,375 shares worth $403K.
- Bourne Lent Asset Management added most to Pacific Biosciences in Q4 2022, an estimated $62.9K increase.
- Bourne Lent Asset Management's biggest Q4 2022 reduction was Bristol-Myers Squibb, cutting an estimated $6.17M.
- Bourne Lent Asset Management fully exited Warner Bros in Q4 2022, selling an estimated $261K.
- Bourne Lent Asset Management's ten largest holdings make up 71% of its $233M portfolio in Q4 2022.
- Bourne Lent Asset Management opened 7 new positions and closed 2 in Q4 2022.
- Bourne Lent Asset Management's portfolio value rose 1.5% quarter-over-quarter to $233M.
Based on Bourne Lent Asset Management's 13F filing for Q4 2022, filed 24 Jan 2023.